Insider Shareholders with Direct Ownership of Edgewise Therapeutics, Inc. (EWTX)
This section provides a comprehensive overview of the insiders with direct ownership of Edgewise Therapeutics, Inc. (EWTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Edgewise Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Novo Holdings
> 10% Shareholder |
6,071,703 | 0 | 6,071,703 $109 Million | 2 |
Sep 14, 2022
Added 7.39%
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
681,812 | 0 | 681,812 $12.3 Million | 1 |
Mar 30, 2021
Added 50.0%
|
R Michael Carruthers
Chief Financial Officer |
119,416 | 93,493 | 35,230 $634,492 | 8 |
May 02, 2024
Reduced 5.77%
|
20,833 | 6,936 | 19,897 $358,344 | 4 |
May 02, 2024
Reduced 15.62%
|
|
15,625 | 0 | 15,625 $281,406 | 1 |
Mar 30, 2021
Added 50.0%
|
|
Kevin Koch
President and CEO |
20,833 | 6,355 | 14,478 $260,748 | 4 |
May 02, 2024
Reduced 17.88%
|
Behrad Derakhshan
Chief Business Officer |
20,416 | 13,465 | 13,422 $241,730 | 10 |
May 02, 2024
Reduced 11.35%
|
10,857 | 0 | 10,857 $195,534 | 1 |
Dec 26, 2023
Added 50.0%
|
|
Alan J Russell
Chief Scientific Officer |
183,001 | 439,863 | 7,238 $130,356 | 31 |
May 02, 2024
Reduced 17.88%
|
John R Moore
General Counsel |
247,876 | 249,810 | 3,252 $58,568 | 48 |
May 02, 2024
Reduced 37.56%
|